Epitopea
Epitopea is a RNA-based immunotherapies developer to treat cancer patients founded in 2021 by Jon Moore, Claude Perreault and Pierre Thibault.
4
Funding Rounds
$58.3m
Money raised
Funding
Funding series
Funding Series Analysis
The company Epitopea has raised a total of $58.26m in funding over 4 rounds.
Key Insights:
- Epitopea Seed Round, October 2024: $31m
- Epitopea Grant Fund, September 2024: $658k
- Epitopea Seed round, April 2022: $13.6m
- Epitopea April 2022 Seed Funding Round: $13m
Epitopea Seed Round, October 2024
$31m
Epitopea Grant Fund, September 2024
$658k
Epitopea Seed round, April 2022
$13.6m
Epitopea April 2022 Seed Funding Round
$13m
Industries
Epitopea is active in the following industries: